Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Bronchial artery embolization is an effective nonsurgical therapy for massive hemoptysis. Routine selection of the bronchial arteries from the aorta usually enables the interventionalist full interrogation and embolization of the culprit vascular abnormality. In problematic cases where bronchial artery access is difficult, a systemic-to-pulmonary arterial shunt can be exploited as a retrograde means of vascular intervention. A case is presented where inaccessibility of a tortuous left bronchial artery was circumvented by accessing the left pulmonary artery, leading to successful embolization and control of hemoptysis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878955 | PMC |
| http://dx.doi.org/10.1016/j.radcr.2016.03.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[A case report of tracheobronchial Dieulafoy's disease].
Zhonghua Jie He He Hu Xi Za Zhi
September 2025
Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Tracheobronchial Dieulafoy's disease (TBDD) is a rare bronchial artery vascular malformation, characterized clinically by sudden, recurrent, and life-threatening massive hemoptysis. This article reports the case of a 9-year-old female patient who presented with massive hemoptysis lasting two weeks. Following ineffective treatment at a local hospital, she was transferred to our institution.
View Article and Find Full Text PDFEvaluation and management of hemoptysis.
JAAPA
September 2025
Clay W. Walker is an assistant professor of family medicine at Mayo Clinic in Phoenix, AZ; director of didactic education and an assistant professor in the PA program at A.T. Still University in Mesa, AZ; and an adjunct assistant professor at Rush University in Chicago, IL. Thomas Hartman is directo
Hemoptysis, defined as the expectoration of blood originating from the lower respiratory tract, is a clinical symptom with a wide differential diagnosis that ranges from benign to life-threatening causes. Common causes vary by geographic region and care setting, with respiratory infections, malignancy, bronchiectasis, and chronic obstructive pulmonary disease being predominant in resource-rich countries and tuberculosis remaining the leading cause in resource-limited areas. Though most cases are mild and self-limited, hemoptysis can be a life-threatening medical emergency; these cases are associated with a mortality exceeding 50%, primarily due to asphyxia.
View Article and Find Full Text PDF(R)-vanzacaftor potentiates BK channels in the absence of CFTR correction or potentiation.
Am J Physiol Cell Physiol
September 2025
Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA.
We previously demonstrated the CFTR correctors VX-445 (elexacaftor) and S-VX-121 (vanzacaftor) potentiate heterologously-expressed BK channels, as well as in primary human bronchial epithelial cells (HBEs). This potentiation of BK resulted in altered vasoreactivity and neuronal excitability. We postulated novel compounds could be identified that would potentiate BK while not affecting CFTR.
View Article and Find Full Text PDFSuccessful Treatment of Aspergilloma With Antifungal Alone: A Case of Conservative Management.
Respirol Case Rep
August 2025
Division of Respiratory Medicine, Department of Internal Medicine Melaka Hospital Melaka Malaysia.
Pulmonary aspergilloma can cause life-threatening haemoptysis. Surgical resection and/or bronchial artery embolization (BAE) are established treatment modalities, but both can be risky in frail patients with comorbidities. Spontaneous regression of aspergilloma with antifungal agents alone is rare.
View Article and Find Full Text PDFPulmonary aspergilloma is an uncommon but potentially life-threatening condition that predominantly affects individuals with pre-existing structural lung disease and immunosuppression. Systemic lupus erythematosus (SLE), especially with long-term immunosuppressive therapy, significantly increases susceptibility to opportunistic infections, including fungal pathogens such as species. These patients are also at heightened risk for a broad range of opportunistic infections, such as species, viral infections such as herpes zoster and cytomegalovirus (CMV), , and pneumonia (PJP).
View Article and Find Full Text PDF